How should you actually handle stacking on TB-500

A reader on r/Peptides asked a version of a question I get constantly: they were already running BPC-157 and wanted to know how to add TB-500 without messing up what they'd already started. Short answer: you don't need a complicated transition plan. TB-500 and BPC-157 stack together from day one for most people, and the main things to get right are the dose, the injection frequency, and understanding that you're running two different repair mechanisms, not doubling up on the same one.

I've had this conversation with a lot of people who are timid about combining compounds, and I get where it comes from. You've read enough forum threads about interactions and half-lives that adding a second peptide feels like it should require some kind of ceremony. It doesn't. Let me walk through what's actually going on and how people run it in practice.

Why these two peptides pair up at all

BPC-157 and TB-500 do different repair jobs and the two jobs happen at once when you run them together. BPC-157 is a 15-amino-acid fragment discovered in gastric juice, and its main trick is driving angiogenesis at the injury site through VEGF signaling, plus activating the FAK-paxillin pathway that lets fibroblasts (your collagen-laying repair cells) migrate in and rebuild tissue. It works locally and fast.

TB-500 is a fragment of thymosin beta-4, a protein your cells use to manage their internal scaffolding. Its core mechanism is actin sequestration: it grabs and releases the building blocks of the cell's cytoskeleton, which is what lets cells crawl toward damaged tissue in the first place. Cells have to migrate to an injury before they can repair it, and that's the piece TB-500 handles at a whole-body level rather than just at one site. TB-500 also drives its own angiogenesis effect and carries anti-inflammatory and anti-fibrotic signaling, down-regulating the inflammatory chemokines that would otherwise push a healing injury toward excess scar tissue instead of organized repair.

Put simply: BPC-157 is the local construction crew, and TB-500 is the logistics that gets cells to the job site and keeps the whole operation systemic. That's the entire case for pairing them, and it's why the combination (branded "Wolverine" in the peptide community) is the default recovery stack at real clinics.

The actual protocol people run

Now the part my lawyer makes me say, and he is right: the doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

With that out of the way, here's what people actually do. BPC-157's short plasma half-life (roughly 40 minutes) is why it's typically dosed once or twice daily, in the 250 to 500 mcg range per injection. TB-500 lasts longer in the body, so it doesn't need daily dosing the way BPC-157 does. The most common convention is a loading phase of 2 to 5 mg of TB-500 twice weekly for the first 4 to 6 weeks, then dropping to a maintenance dose of 2 to 5 mg once weekly or every other week.

There's also a simpler daily-stacked version some people prefer inside the Wolverine pairing: 300 to 500 mcg of TB-500 alongside the same range of BPC-157, daily, mixed in one vial. This trades TB-500's usual twice-weekly cadence for convenience, since you're already drawing up BPC-157 every day anyway. Neither approach has a human dose-finding trial behind it; both are community-converged protocols built off animal dosing scaled to human weight and years of practitioner and forum experience, stated here plainly as that.

One onset detail worth knowing before you start: some people report mild flu-like symptoms or transient lethargy in the first week of TB-500. That's an early-onset, self-limiting response.

Reconstitution math for a 10 mg TB-500 vial: mix with 2 mL of bacteriostatic water for 5 mg/mL, so 0.1 mL on an insulin syringe (10 units) delivers 500 mcg. Add the water slowly down the vial wall and swirl gently. I'll flag this because it comes up constantly: swirling does not denature the peptide. Heat, prolonged time in solution, light, oxidation, and repeated freeze-thaw cycles are the actual degradation drivers.

What to watch as you combine them

Injection-site reactions (redness, mild swelling) are the most common side effect for both peptides, so rotate sites regardless of whether you're running one or two compounds. If you're new to injecting daily, an auto-injector pen can make a two-peptide daily routine a lot less tedious than drawing up separate syringes every time.

The one caution worth taking seriously with either peptide is a personal or active history of cancer. Both TB-500 and BPC-157 work partly through angiogenesis, the same blood-vessel-growth pathway that tumors can exploit, and that's a real enough theoretical overlap that it deserves a conversation with an oncologist before you start. It's mechanism-based caution, but I'd rather flag it plainly than skip it.

Beyond that, the main variable that actually determines whether your stack does anything is the same variable that determines whether any peptide protocol works: whether your vial contains what the label says. TB-500 in particular gets sold under inconsistent naming, sometimes as the short synthetic fragment and sometimes as the full-length molecule, so a third-party certificate of analysis matters more here than with most compounds. If you want the deeper mechanism breakdown on either peptide, the TB-500 and BPC-157 pages cover the full evidence picture, including what's animal data versus what's been tested in humans.

If you're already running BPC-157 and wondering whether TB-500 will complicate anything, it won't. Add it at whatever dose fits your goal, give the combination a few weeks to do its work, and don't overthink the sequencing. I see people spend more energy worrying about the "right" way to combine two peptides than they spend on the sleep and protein intake that actually determine whether either one has raw material to work with.